NM Gavryliuk1, ІYa Hospodarskii1*, OV Prokopchuk1, ОV Bushtynska1, MYe Havrylyuk2 and OA Kozak1
1Department of Higher Nursing Education, Patient Care and Clinical Immunology, I. Horbachevsky Ternopil National Medical University, Ukraine 2Department of Internal Medicine No.1, I. Horbachevsky Ternopil National Medical University, Ukraine
*Corresponding Author: ІYa Hospodarskii, Department of Higher Nursing Education, Patient Care and Clinical Immunology, I. Horbachevsky Ternopil National Medical University, Ukraine.
Received: November 30, 2021; Published: December 23, 2021
Liver fibrosis is a significant medical and economic problem in many countries, particularly developed ones, with excess incidence of overweight and obesity, as well as in the countries with high incidence of viral hepatitis. Taking into account the significant progress in the molecular understanding of liver fibrosis, the problem of early diagnostics, disease course prediction and search for effective pathogenetically substantiated approaches to its treatment remains important. The presented article highlights the main methods of posthepatitis liver fibrosis diagnostics after elimination of viral hepatitis type C and in patients with non-alcoholic fatty liver disease affected by overweight and obesity by evaluating fibrosis serum markers. Authors highlighted connections with non-alcoholic fatty liver disease, posthepatitis liver fibrosis after elimination of viral hepatitis type C in patients with overweight and obesity, perspective directions for the use of these data are also formulated.
KeywordsPosthepatic Fibrosis; NAFLD; Overweight; FibroTest; FIB-4; TGF-β1
Citation: ІYa Hospodarskii., et al. “The Results of Serum Markers of Liver Fibrosis in Patients with Posthepatic Fibrosis and in Patients with Non-alcoholic Fatty Liver Disease Depending on Body Weight". Acta Scientific Gastrointestinal Disorders 5.1 (2022): 36-40.
Copyright: © 2022 ІYa Hospodarskii., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.